TORONTO, Feb. 26, 2018 /CNW/ - Cronos Group Inc.
(TSX-V: MJN) (OTC Nasdaq Int'l Designation: PRMCF) ("Cronos
Group" or the "Company") is pleased to announce that
trading of its common shares in the
United States will be elevated from the Nasdaq International
Designation program to the Nasdaq Global Market
("Nasdaq").
Cronos Group expects that its common shares will begin trading
on Nasdaq on February 27, 2018 under
the trading ticker symbol "CRON." Cronos Group will
retain its listing on the TSX Venture Exchange ("TSX-V")
under the symbol "MJN."
"This up listing to NASDAQ is a major corporate milestone and
reflects the significant progress we have made in strengthening our
corporate governance and expanding our global footprint," said
Mike Gorenstein, CEO of Cronos
Group. "We believe this will increase long term shareholder value
by improving awareness, liquidity, and appeal to institutional
investors."
About Cronos Group
Cronos Group is a globally diversified and vertically integrated
cannabis company with a presence across four continents. The
Company operates two wholly-owned Canadian Licensed Producers
regulated under Health Canada's Access to Cannabis for Medical
Purposes Regulations: Peace Naturals Project Inc. (Ontario), which was the first non-incumbent
medical cannabis license granted by Health Canada, and Original BC
Ltd. (British Columbia), which is
based in the Okanagan Valley. The Company has multiple
international production and distribution platforms including:
Cronos Israel and Cronos Australia. Through an exclusive
distribution agreement, Cronos Group has access to over 12,000
pharmacies in Germany. The Company
is rapidly expanding its global footprint as it focuses on building
an international iconic brand portfolio and developing disruptive
intellectual property. Cronos Group is committed to building
industry leading companies that transform the perception of
cannabis and responsibly elevate the consumer experience.
Forward-Looking Statements
This press release contains forward-looking statements. These
forward-looking statements, by their nature, require the Company to
make certain assumptions and necessarily involve known and unknown
risks and uncertainties that could cause actual results to differ
materially from those expressed or implied in these forward-looking
statements. Words such as "may", "will", "would", "could",
"expect", "believe", "plan", "anticipate", "intend", "estimate",
"continue", or the negative or comparable terminology, as well as
terms usually used in the future and the conditional, are intended
to identify forward-looking statements. Information contained in
forward-looking statements is based upon certain material
assumptions that were applied in drawing a conclusion or making a
forecast or projection. The Company considers its assumptions to be
reasonable based on information currently available, but cautions
the reader that its assumptions regarding future events, many of
which are beyond the control of the Company, may ultimately prove
to be incorrect since they are subject to risks and uncertainties
that affect the Company and its business.
For additional information with respect to these and other
factors and assumptions underlying the forward-looking statements
made in this press release, refer to the Company's most recent
Annual information Form filed on SEDAR. The forward-looking
information set forth herein reflects the Company's expectations as
at the date of this press release and is subject to change after
such date. The Company disclaims any intention or obligation to
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, other than
as required by law.
SOURCE Cronos Group Inc.